177 related articles for article (PubMed ID: 16131450)
21. [Oncologic aspects of Clostridium difficile].
Telekes A
Orv Hetil; 2016 Jul; 157(28):1110-6. PubMed ID: 27397423
[TBL] [Abstract][Full Text] [Related]
22. [Dihydropyrimidine dehydrogenase deficiency causes severe adverse effects of capecitabine].
Inoue H; Sato Y; Shintani S; Tanabe H; Bamba H; Komai Y; Nakamura T; Imai T; Andou A
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):290-298. PubMed ID: 29526981
[TBL] [Abstract][Full Text] [Related]
23. Lethal pseudomembranous colitis in an immunocompetent patient.
Gas-Ruiz C; Ros-López SE; Vilardell-Villella F; Mias-Carballal C; Villalobos-Mori R; De-la-Fuente-Juárez MC; Baena-Fustegueras JA; Olsina-Kissler JJ
Rev Esp Enferm Dig; 2015 Feb; 107(2):117-9. PubMed ID: 25659396
[No Abstract] [Full Text] [Related]
24. Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
Vesikari T; Mäki M; Baer M; Grönroos P
Acta Paediatr Scand; 1984 Jan; 73(1):135-7. PubMed ID: 6702443
[TBL] [Abstract][Full Text] [Related]
25. [A case of pseudomenbranous colitis after paclitaxel and carboplatin chemotherapy].
Yang SW; Moon W
Korean J Gastroenterol; 2009 Nov; 54(5):328-32. PubMed ID: 19934614
[TBL] [Abstract][Full Text] [Related]
26. [Colitis due to chemotherapeutic agent].
Yang XY
Zhonghua Fu Chan Ke Za Zhi; 1990 Sep; 25(5):272-4, 315. PubMed ID: 2178081
[TBL] [Abstract][Full Text] [Related]
27. [Severe 5-fluorouracil induced toxicity associated with dihydropyrimidine dehydrogenase deficiency].
López Sobella M; Criado Illana MT; Esteban Herrera B; López Arranza MC
Farm Hosp; 2008; 32(1):54-6. PubMed ID: 18426703
[No Abstract] [Full Text] [Related]
28. A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Obi EE; McDonald A; Kemp E
Cutan Ocul Toxicol; 2011 Jun; 30(2):157-9. PubMed ID: 21077799
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiology of Clostridium difficile infection].
Szczesny A; Martirosian G
Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.
Andréjak M; Schmit JL; Tondriaux A
Drug Saf; 1991; 6(5):339-49. PubMed ID: 1930740
[TBL] [Abstract][Full Text] [Related]
31. Pseudomembranous colitis: Not always Clostridium difficile.
Tang DM; Urrunaga NH; von Rosenvinge EC
Cleve Clin J Med; 2016 May; 83(5):361-6. PubMed ID: 27168512
[TBL] [Abstract][Full Text] [Related]
32. 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case.
Steiner M; Seule M; Steiner B; Bauer I; Freund M; Köhne CH; Schuff-Werner P
J Clin Pathol; 2005 May; 58(5):553-5. PubMed ID: 15858133
[TBL] [Abstract][Full Text] [Related]
33. Capecitabine induced colitis.
Maggo G; Grover SC; Grin A
Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
[TBL] [Abstract][Full Text] [Related]
34. Fatal Clostridium difficile infection associated with vinorelbine chemotherapy: case report and literature review.
Ansari J; Choo B; Fernando I
J Infect Chemother; 2010 Jun; 16(3):210-2. PubMed ID: 20198401
[TBL] [Abstract][Full Text] [Related]
35. Recurrent pseudomembranous colitis as a cause of recurrent severe sepsis.
Eckel F; Huber W; Weiss W; Lersch C
Z Gastroenterol; 2002 Apr; 40(4):255-8. PubMed ID: 11961735
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases.
Miller SD; Blake M; Miliotis M; Still C; Taubin A; Koornhof HJ
S Afr Med J; 1983 Jun; 63(24):936-9. PubMed ID: 6857419
[TBL] [Abstract][Full Text] [Related]
37. [Colitis associated with C. difficile].
Mironov IL; Ratnikova LI; Pirogov DV; Mil'chenko IB
Eksp Klin Gastroenterol; 2014; (11):65-8. PubMed ID: 25842668
[TBL] [Abstract][Full Text] [Related]
38. Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency.
Saif MW; Diasio RB
Cancer Chemother Pharmacol; 2016 Jul; 78(1):151-6. PubMed ID: 27278667
[TBL] [Abstract][Full Text] [Related]
39. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Cordier PY; Nau A; Ciccolini J; Oliver M; Mercier C; Lacarelle B; Peytel E
Cancer Chemother Pharmacol; 2011 Sep; 68(3):823-6. PubMed ID: 21553285
[TBL] [Abstract][Full Text] [Related]
40. A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimen.
Zaanan A; Pallet N; Narjoz C; Loriot MA; Hafliger É
Eur J Cancer; 2024 Jul; 205():114102. PubMed ID: 38723381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
